Patients in Greece are facing delays of up to two years in accessing new medications, with reports indicating a significant decline in the number of drugs reaching the Greek market. This situation raises alarms amid Europe's advancements in medical innovations.
Reports from the White House indicate that former President Donald Trump's agreements with pharmaceutical companies may lead to savings of up to <strong>$529 billion</strong> for the U.S. economy over the next decade. This news comes at a critical time as the U.S. economy seeks to recover from the impacts of the COVID-19 pandemic.
A job fair was inaugurated in Assiut featuring the participation of 40 pharmaceutical companies, aiming to provide new job opportunities for youth and enhance the pharmaceutical sector in the region. This event is part of the Egyptian government's efforts to support the local economy and encourage youth engagement in the job market.
Iranian Foreign Minister Abbas Araghchi has vowed severe retaliation from the Iranian armed forces against Israel following attacks on pharmaceutical companies. This threat comes amid escalating tensions between Iran and Israel.
The CEO of Apyvax stated that the company is not in a hurry to sell itself, planning to raise funds after releasing critical trial data in June. This comes amid strong rumors of a potential acquisition by major pharmaceutical companies.